drugset / Trial / NCT04720963

Intranasal Remimazolam for Premedication in Pediatric Patient

NCT04720963

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Anesthetic inhalation induction could be one of the most stressful experiences for children during the perioperative period, with almost 50% of them showing anxiety. It is an essential challenge for pediatric anesthesiologists on how to decrease anxiety for children in the operating room (OR) environment and to facilitate a smooth induction of anesthesia. Various factors like parental separation, unfamiliar surroundings, fear of physicians and needle injections can increase their preoperative anxiety. The researchers conducted the current study to investigate whether intranasal remimazolam can reduce anxiety in children before surgery.

Timeline

Start
2021-02-07
Primary completion
2022-02-28
Completion
2022-02-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 2 ug/kg Intranasal
Subject Remimazolam Small molecule 1.5 mg/kg Intranasal